Cardinal Health reported fourth-quarter fiscal 2026 revenue of $63.7 billion, a 6% increase year-over-year, with GAAP diluted EPS rising 70% to $1.70. Full-year 2026 revenue reached $254.2 billion (up 14%), and non-GAAP diluted EPS increased 37% to $11.26. The company declared a regular quarterly dividend of $0.5158 per share, payable October 15, 2026, to shareholders of record on October 1, 2026. Additionally, the board approved a $5.0 billion incremental share repurchase authorization and completed an additional $350 million accelerated share repurchase. Cardinal Health provided fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60, representing 13% to 15% growth. Cardinal Health operates in the healthcare distribution industry, providing pharmaceuticals, medical supplies, and related services.
